5,770 followers
#New Cochrane protocol: Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for COPD https://t.co/8lWIRgmWcQ
#New Cochrane protocol: Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for COPD https://t.co/8lWIRgmWcQ